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Abstract
Background: The fetal and adult globin genes in the human b-globin cluster on chromosome 11 are sequentially
expressed to achieve normal hemoglobin switching during human development. The pharmacological induction
of fetal g-globin (HBG) to replace abnormal adult sickle b
S-globin is a successful strategy to treat sickle cell disease;
however the molecular mechanism of g-gene silencing after birth is not fully understood. Therefore, we performed
global gene expression profiling using primary erythroid progenitors grown from human peripheral blood
mononuclear cells to characterize gene expression patterns during the g-globin to b-globin (g/b) switch observed
throughout in vitro erythroid differentiation.
Results: We confirmed erythroid maturation in our culture system using cell morphologic features defined by Giemsa
staining and the g/b-globin switch by reverse transcription-quantitative PCR (RT-qPCR) analysis. We observed maximal g-
globin expression at day 7 with a switch to a predominance of b-globin expression by day 28 and the g/b-globin
switch occurred around day 21. Expression patterns for transcription factors including GATA1, GATA2, KLF1 and NFE2
confirmed our system produced the expected pattern of expression based on the known function of these factors in
globin gene regulation. Subsequent gene expression profiling was performed with RNA isolated from progenitors
harvested at day 7, 14, 21, and 28 in culture. Three major gene profiles were generated by Principal Component
Analysis (PCA). For profile-1 genes, where expression decreased from day 7 to day 28, we identified 2,102 genes down-
regulated > 1.5-fold. Ingenuity pathway analysis (IPA) for profile-1 genes demonstrated involvement of the Cdc42,
phospholipase C, NF-Kb, Interleukin-4, and p38 mitogen activated protein kinase (MAPK) signaling pathways.
Transcription factors known to be involved in g-and b-globin regulation were identified.
The same approach was used to generate profile-2 genes where expression was up-regulated over 28 days in
culture. IPA for the 2,437 genes with > 1.5-fold induction identified the mitotic roles of polo-like kinase, aryl
hydrocarbon receptor, cell cycle control, and ATM (Ataxia Telangiectasia Mutated Protein) signaling pathways;
transcription factors identified included KLF1, GATA1 and NFE2 among others. Finally, profile-3 was generated from
1,579 genes with maximal expression at day 21, around the time of the g/b-globin switch. IPA identified
associations with cell cycle control, ATM, and aryl hydrocarbon receptor signaling pathways.
Conclusions: The transcriptome analysis completed with erythroid progenitors grown in vitro identified groups of genes
with distinct expression profiles, which function in metabolic pathways associated with cell survival, hematopoiesis, blood
cells activation, and inflammatory responses. This study represents the first report of a transcriptome analysis in human
primary erythroid progenitors to identify transcription factors involved in hemoglobin switching. Our results also
demonstrate that the in vitro liquid culture system is an excellent model to define mechanisms of global gene
expression and the DNA-binding protein and signaling pathways involved in globin gene regulation.
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The fetal and adult globin genes in the b-globin cluster
on chromosome 11 are expressed in a stage-specific
manner during development to achieve the normal g/b-
globin gene switch after birth [1-4]. A large group of
hemoglobin disorders result from mutations in the b-
like globin genes including sickle cell anemia caused by
an A to T mutation in HBB (b-globin) at the sixth posi-
tion to produce b
S-globin [5]. The association of two a-
globin chains with two b
S-globin subunits forms hemo-
globin S which undergoes non-covalent polymerization
due to abnormal intermolecular contacts under low oxy-
gen conditions. This produces red blood cell sickling
leading to the clinical symptoms observed in sickle cell
anemia [6].
Extensive research has shown the beneficial effect of g-
globin reactivation by pharmacologic methods to induce
fetal hemoglobin as a treatment modality for sickle cell
patients. One such drug hydroxyurea was approved in
1998 [7]. Numerous laboratories have ongoing efforts to
identify additional less toxic agents that induce fetal
hemoglobin however few have reach clinical trials [8,9].
Therefore defining molecular mechanisms of globin
gene regulation provides an approach to define specific
strategies for g-globin gene reactivation. With the avail-
ability of high throughput genomic methods, research
aimed at the discovery of global mechanisms of gene
regulation using in vitro models is now feasible [10] to
establish personalized medical therapy [11].
To date, a limited number of transcriptome profiles
have been reported for global genomic analysis in
human erythroid cells. For example, K562 cells induced
with hemin [12] were used to characterize transcrip-
tomes related to drug induced erythroid differentiation.
Subsequently, five studies have been published to char-
acterize gene profiling during normal human erythroid
differentiation using in vitro liquid culture systems
[13-17]. Recently, Merryweather-Clarke et al. [17] used
peripheral blood mononuclear cells combined with
fluorescent activated cell sorting for the CD71 and
CD36 surface markers. They analyzed expression data
generated from erythroid progenitors isolate at the var-
ious stages of erythropoiesis and identified proteins with
undiscovered function in erythroblast. Collectively, these
studies generated significant findings regarding the ery-
throid transcriptome however our study is the first to
characterize the transcriptome associated with the g/b-
globin switch.
To achieve this end, microarray analysis was per-
formed using the Illumina whole genome platform to
define global gene expression patterns associated with
the g/b-globin switch during primary erythroid matura-
tion. We observed maximal g-globin and b-globin gene
expression at day 7 and 28 respectively with the g/b-glo-
bin switch occurring around day 21. We defined three
major gene profiles consistent with a potential role of g-
globin activator (profile-1) with gene silencing from day
7t od a y2 8 ;b-globin activator (profile-2) showing
increased gene transcription from day 7 to day 28 and
profile-3 genes defined by maximal expression at day 21
when the g/b-globin switch was observed. Using > 1.5-
fold change in expression, we identified 2,102 profile-1
genes some of which were involved in cell signaling
through the p38 and ERK MAPK and erythropoietin
receptor pathways. Another 2,437 profile-2 genes with
patterns consistent with a positive role in b-globin regu-
lation and 1,579 profile-3 genes that might play a role in
the g/b-globin switch were identified. A global approach
to define the transcriptome involved in globin gene
expression during erythropoiesis can be used to generate
testable hypotheses of g-globin regulation and the devel-
opment of strategies for fetal hemoglobin induction to
treat sickle cell anemia.
Results and discussions
The g/b-globin switch is observed in the one-phase liquid
culture system
To study global mechanisms of globin gene regulation,
we established the in vitro one-phase liquid culture sys-
tem developed by Uddin et al. [18]. We modified this
system using, human peripheral blood mononuclear
cells grown in the presence of stem cell factor (50 ng/
mL), Interleukin-3 (50 ng/mL), and erythropoietin 4 IU/
mL from day 0. Cells were harvested every two to three
days for cell morphology by Giemsa stain and g-globin
and b-globin gene mRNA levels were quantified by RT-
qPCR analysis (see Methods). From day 16 to day 31,
the percentage of early and late erythroid progenitors
increased from 5% to 84% (Figure 1A). Early erythroid
cells possess a deep blue cytoplasm consistent with
basophilic erythroblasts followed by maturation into late
orthochromatophilic erythroblasts by day 28 (data not
shown). During the same time period g-globin and b-
globin gene expression was monitored by RT-qPCR. We
observed progressive g-globin silencing and concomitant
b-globin activation with the g/b-globin switch occurring
around day 21 (Figure 1B) recapitulating human hemo-
globin switching observed during development.
We next analyzed the response of the g-globin gene in
more detail to establish our system as a good model for
performing transcriptome analysis. At birth, fetal hemo-
globin composes 80-90% of the total hemoglobin
synthesized and it gradually decreases to < 1% by 10
months in normal infants [19]. Fetal hemoglobin is a
heterogeneous mixture of g-globin polypeptide chains
containing either glycine (Gg)o ra l a n i n e( A g)a tr e s i d u e
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Page 2 of 18136 [20]. At birth Gg-chains predominate, however, a
switch to predominantly Ag- c h a i n sa r i s e sd u r i n gt h e
first year of life going from a 3:1 to 1:1 Gg:Ag ratio. As
s h o w ni nF i g u r e1 C ,t h er a t i oo fG g:Ag-globin expres-
sion changed from 2:1 at day 7, to 1:1 by day 31 a pat-
tern similar to that observed after birth [21].
Subsequently, we tested the ability to activate g-globin
expression in our human erythroid culture system using
hemin, a known fetal hemoglobin inducer. Hemin acti-
vated g-globin 2.3-fold at day 11 in contrast to a lack of
induction at day 28 (Figure 1D) suggesting the ability of
hemin to further enhance a transciptionally active g-glo-
bin gene at day 11. By contrast, day 28 cultured cells
carrying a silenced g-globin gene were resistant to
induction by hemin. These data established our one-
phase liquid culture as a model to study erythropoiesis
that can be used to define the erythroid transcriptome
associated with the g/b-globin switch.
Data mining approach
Based on the timing of the g/b-globin gene switch, we
performed microarray analysis to define the erythroid
cells transcriptome. Our data mining approach (Figure
2) consisted of four steps: 1) data normalization after
microarray chip hybridization using Model-Based Back-
ground Correction (MBCB) for BeadArrays and quartile
normalization; 2) time-course gene expression profiling
using PCA and the confirmation of gene profiles for a
subset of genes by RT-qPCR analysis; 3) gene classifica-
tion using DAVID (the Database for Annotation, Visua-
lization and Integration Discovery) gene ontogeny (GO);
and 4) functional genomics to define the signaling
Figure 1 The g/b-globin switch is recapitulated in the one-phase liquid culture system. Cells grown in the one-phase system were
harvested every 2-3 days and analyzed as follows (see Methods). A) Cell morphology was determined by Giemsa stain and different cell types
classified based on standard morphologic features. B) RT-qPCR analysis was performed to determine changes in g-globin and b-globin mRNA
levels during erythroid maturation. C) RT-qPCR was performed with Gg and Ag specific primers to determine the Gg:Ag mRNA ratio during
erythropoiesis. Ag-globin expression was normalized to one (white bars) and the relative changes in Gg-globin mRNA are shown in the black
bars. D) Progenitors were induced on day 11 or day 28 with 50 μM hemin (HE) for 72 hrs and then RT-qPCR was completed.
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Ingenuity Pathway Analysis (IPA). In silico analysis with
Transcription Element Search Site (TESS), TFSEARCH,
Weeder H, and FIRE platforms was also performed to
identify transcription factors with predicted binding sites
in the b-globin locus.
Data collection and gene expression profiling
We collected three RNA samples at day 7, 14, 21, and
28 which allowed us to perform gene expression profil-
ing over a time course. The advantage of this approach
is the use of well-established time-course algorithms for
data mining. However, the variability that can occur at
different times in culture can introduce errors in gene
expression data, but replicate samples help to address
this concern. RNA quality check was performed prior to
microarray analysis on the Illumina HumanWG-6V2
Expression BeadChip containing 48,700 probes on the
Bio-Rad Experion system. Automated electrophoresis
qualities confirmed RQI (RNA Quality Index) values >
8.0 for all samples included in our microarray analysis
(Additional file 1: Figure S1). The raw data generated
are summarized in Additional file 2: Table S1, Addi-
tional file 3: Table S2, Additional file 4: Table S3, Addi-
tional file 5: Table S4.
After the raw data was normalized several gene probes
including S18, S28, DDX5 and ACTB were used to
determine data consistency. The results show no signifi-
cant differences (p > 0.05) in expression across all
microarrays for the internal control genes. We also
observed that the expression of erythroid cell biomar-
kers such as CD36 and glycophorin A (GPA) signifi-
cantly increased (44-fold to 266-fold) from day 7 to day
28 (p < 0.001) (Figure 3A); however CD71 levels
increased 7-fold (p < 0.001) followed by slightly
decreased expression by day 28. These findings are con-
sistent with the expression patterns of cell surface mar-
kers during normal human erythroid differentiation
[22,23].
We next examined the expression profiles of genes
known to be involved in g-globin and b-globin regula-
tion prior to global data mining. The following genes
including GATA2 [24], cJun [25], KLF2 [26], SATB1
[27], KLF4 [28], FOS [29], IKZF1 [30] and RUNX2 [31],
which have been reported to be associated with g-globin
regulation were analyzed (Figure 3B). Simultaneous with
g-globin silencing, we observed decreased expression
from day 7 to day 28 for G A T A - 1 ,K L F 2 ,K L F 4 ,F O S ,
SABT1, cJun, IKFZ1 and RUNX2 among others in agree-
ment with published data.
Genes previously shown to be associated with b-globin
regulation including KLF1 [32], GATA1 [33], NFE2 [34],
FOG1 [35] and FOXM1 [16] were examined as well. We
observed significant KLF1 (108-fold; p <0 . 0 1 )a n d
GATA1 (112-fold) induction compared to 17.5-fold
induction of NFE2, FOG1 (4.6-fold) and FOXM1 (9.6-
fold) from day 7 to day 28, findings consistent with pub-
lished results (Figure 3C). These data support our line of
reasoning that whole genome gene profiling might iden-
tify other transcription factors involved in globin gene
regulation.
Before data mining, the normalized microarray data
was examined in a multiple regression algorithm to
study chip-chip reproducibility (Additional file 1: Figure
S4A). For the three chips analyzed at day 7 the adjusted
R
2 = 0.99 (F-value 4.94E + 0.6 and P-value 2.2E-16), for
day 14 triplicates the adjusted R
2 = 0.98 (F-value 2.96E
+ 0.6 and P-value 2.2E-16), for day 21 chips, the
adjusted R
2 = 0.99 (F-value 3.51E + 0.6 and P-value
2.2E-16), and for day 28 triplicates the adjusted R
2 =
Principal
Component
Analysis
DAVID
Gene
Ontology
TESS
TFSEARCH
Ingenuity
Pathway
Analysis
Data                      Gene Gene                   Functional 
Normalization Profiling               Classification            Genomics
Model-Based
Background
Correction
RT-qPCR
Confirmation
Figure 2 Data mining strategy. Shown is a schematic diagram outlining our genomic bioinformatics approach for the data generated by
microarray analysis.
Li et al. BMC Genomics 2012, 13:153
http://www.biomedcentral.com/1471-2164/13/153
Page 4 of 180.99 (F-value 4.92E + 0.6 and P-value 2.2E-16). These
data demonstrate a high correlation of data reproduci-
bility between microarray chips.
Initial gene profiling studies were conducted by Princi-
pal Component Analysis (PCA), which is an approach to
identify patterns in large datasets. PCA involves a multi-
variate mathematical procedure that transforms a num-
ber of correlated variables into a smaller number of
uncorrelated variables called principal components. The
first principal component accounts for as much of the
variability in the dataset as possible, and each succeed-
ing component accounts for the remaining variability.
Normalized data were used for PCA to define three
major expression profiles including genes silenced from
day 7 to day 28 (profile-1), genes activated over the cul-
ture period (profile-2) and genes with maximal expres-
sion at day 21 (profile-3) during the time of the g/b-
globin switch.
Because our genomics data were mined to follow the
expression patterns of the g-a n db-globin genes pat-
terns, we chose a statistical analysis consisting of F-dis-
tribution with the Analysis of Variance (ANOVA) value
= 0.01 and False Discovery Rate (FDR) = 0.05. Our goal
was to maintain globin gene expression profiles there-
fore permutation analysis was not conducted. To estab-
lish gene subsets for our subsequent functional
genomics analysis, we identified gene with > 1.25-, >
1.5- and > 2-fold change in expression from day 7 to
day 28 by PCA (Table 1). For the highest stringency of
2-fold, we observed 492, 357, and 325 genes for profile-
1, -2 and -3 respectively. The PCA data for genes with >
1.5-fold differential expression are summarized in Addi-
tional file 6: Table S5; these gene were used for the hier-
archical cluster studies shown in Figure 4B which
further illustrates the three major gene profiles consis-
tent with the PCA data.
Figure 3 Gene expression analysis of transcription factors known to regulate globin gene expression. A) Gene expression patterns for
established erythroid markers are shown. Note the different scales for the left and right Y-axis to reflect the magnitude of difference in gene
expression. Shown is the mean ± SEM; *** = p < 0.001. B) Time-course curves of genes previously reported to be involved in g-globin regulation
are shown; * = p < 0.05; ** = p < 0.01. C) Graphed is the expression profiles for genes known to regulate b-globin expression. The raw data for
the genes shown are included in Additional file 2: Table S1, Additional file 3: Table S2, Additional file 4: Table S3, Additional file 5: Table S4.
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tern obtained by microarray with RT-qPCR analysis.
Therefore, we confirmed the microarray data for 37
experimental genes chosen from profile-1, profile-2, and
internal controls. As shown in Table 2, 93.5% (29 out of
31) of gene expression patterns identified by microarray
analysis were confirmed by RT-qPCR. Of note are simi-
lar patterns for the hematopoietic transcription factors
KLF1, NFE2 and GATA1 however the magnitude of
change was different. To further validate our microarray
data, regression analysis was completed for the two data
sets. Our results showed that gene expression patterns
obtained by RT-qPCR analysis correlated to that
observed by microarray assay. For example, profile-1
genes including GATA2 showed R
2 =0 . 8 0 ,p = 0.104
and for SATB1 R
2 = 0.977, p = 0.012. The same analysis
for profile-2 genes showed KLF1 with a R
2 =0 . 9 1 ,p =
0.045, GATA1 (R
2 =0 . 9 9 ,p =0 . 0 0 3 ) ,NFE2 (R
2 =0 . 7 5 5 ,
p =0 . 1 3 1 )a n dFOG1 (R
2 =1 ,p =0 . 0 0 ) .H o w e v e r ,n o t
all fold change in gene expression correlate between the
two techniques which have been reported by other
investigators [36,37]. In our study, c-Myc,a n d18S show
disparate results that might reflect differences in sensi-
tivity of the two techniques. Inconsistencies for 18S
rRNA expression due to technical issue such as mRNA
degradation have been reported [38]. Overall, we
observed a high correlation between data generated by
microarray and RT-qPCR to support the accuracy of
our gene profiling approach.
DAVID gene ontogeny (GO) gene function analysis
To properly classify gene function, the transcriptome
generated from microarray analysis was analyzed by GO
software to: a) address whether or not the data mining
correctly identified related genes expressed in the
expected cell type using the Kappa score; b) define func-
tional annotation and transcriptome categories based on
biological processes, cellular components and molecular
function to address the enriched relationships among
many genes; and c) reflect the individual GO functional
level by over-representation with higher numbers of
genes and significant p-values in the GO terms to deter-
mine and classify GO groups [39,40]. We completed a
GO clustering analysis for each gene profile subset with
> 1.5-fold change in expression during erythroid
maturation using the DAVID platform [41]. For inter-
pretation of our analysis, the higher the Kappa score for
a given genomic profile, the stronger the agreement
with the cell type from which the specimens were
extracted; if Kappa = 1, then there is perfect agreement
Table 1 Summary of Principle Component Analysis
> 1.25-fold > 1.5-fold* > 2-fold
profile-1 3,317 1,610 492
profile-2 3,105 2,080 357
profile-3 2,120 1,254 325
*Genes with > 1.5-fold change were used for the subsequent bioinformatics
analyses
Days
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Day
B
7    14    21   28  7    14     21   28   7    14     21     28
profile-1         profile-2            profile-3       
A
-2.0   0.0  2.0
Figure 4 Principal component analysis (PCA). A) PCA was performed for gene subsets with > 1.5-fold change in expression over the 28-day
culture period (See Methods). The results are shown for the three major gene profiles generated by PCA. The red line represents the mean
value of time-course changes (days 7, 14, 21 and 28). B) Expression values were normalized to the mean values of Day 7 samples. The resultant
log2 ratios at each day were averaged and displayed in the heatmap. The color bar indicates log2 ratio of change in gene expression.
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values for each GO term are shown in Additional file 7:
Table S6.
For profile-1 genes, Kappa = 1 was obtained for the
GO term hematopoiesis (Enrichment score 15.91, p =
7.7E-10). Profile 2 genes were highly associated with the
GO term erythrocyte differentiation, Kappa = 1 (Enrich-
ment score 2.5, p = 1.5E-4). On the other hand, profile-
3 genes had a Kappa = 1 for the GO term macromole-
cular complex subunit organization (Enrichment score
5.27, p = 3.8E-7). This latter term describes a process by
which macromolecules aggregate, or disaggregate to
reform, disassembly, or alter macromolecular complexes.
Reorganization of these complexes has been largely
reported in protein expression changes and gene switch-
ing produced in cells infected with viruses, bacteria and
parasite [42]. We speculate that macromolecule complex
reorganization may occur during the g/b-globin switch.
To further characterize the genes identified in each
p r o f i l ew eu s e do v e r - r e p r esentation to classify GO
groups. In this analysis we investigated two major GO
categories where 1) biological processes with 30 sub-
groups and 2) molecular function with 20 subgroups
were identified (p < 0.05). For biological processes, the
following subgroups are highlighted for profile-1: 47
genes were over-represented in hemopoiesis (Enrich-
ment score 15.91, p = 7.7E-10) and 85 genes in cell
activity (Enrichment score 15.91, p = 1.4E-29). We also
observed 121 profile-2 genes related to cellular prolifera-
tion (Enrichment score 25.4, p = 1.43E-32) and 8 genes
related to heme biosynthesis (Enrichment score 3.27, p
= 6.5E-6). Finally, 81 genes in profile-3 were associated
with nucleotide metabolism and DNA processing
(Enrichment score 5.14, p = 1.1E-6). The GO subgroups
identified would be predicted since erythropoiesis
involves actively dividing hematopoietic cells, which
Table 2 Comparison between microarray and RT-qPCR mRNA levels
Number Gene sources Symbol Microarray(Mean fold change) RT-qPCR(Mean fold change)
D7 D14 D21 D28 D7 D14 D21 D28
1 profile-1 STAT5A 1.00 0.50 0.99 0.35 1.00 1.18 0.56 0.46
2 profile-1 DBP 1.00 1.13 0.28 0.67 1.00 0.08 0.28 0.48
3 profile-1 FOXQ1 1.00 0.66 0.57 0.54 1.00 0.00 0.05 0.03
4 profile-1 NFIL3 1.00 0.75 0.23 0.19 1.00 0.10 0.35 0.26
5 profile-1 MTF1 1.00 0.66 0.50 0.75 1.00 0.58 0.97 0.82
6 profile-1 JUN 1.00 0.79 0.43 0.68 1.00 0.05 1.10 0.22
7 profile-1 KLF2 1.00 0.86 0.20 0.18 1.00 0.08 0.11 0.11
8 profile-1 CEBPA 1.00 1.20 0.09 0.10 1.00 0.02 0.18 0.17
9 profile-1 CREBBP 1.00 0.85 0.70 0.99 1.00 0.81 0.65 0.61
10 profile-1 SP3 1.00 0.84 0.88 0.87 1.00 0.98 0.85 0.47
11 profile-1 SATB1 1.00 0.94 0.28 0.26 1.00 0.80 0.24 0.15
12 profile-1 c-Myc 1.00 0.95 1.05 0.62 1.00 11.9 14.63 11.95
13 profile-1 GATA2 1.00 1.87 0.95 0.59 1.00 4.00 1.20 1.20
14 profile-1 KLF11 1.00 1.22 0.58 0.70 1.00 2.16 0.58 0.70
15 profile-2 FOG1 1.00 0.96 3.64 4.63 1.00 0.99 3.70 4.70
16 profile-2 USF1 1.00 1.01 0.85 1.26 1.00 0.71 1.45 2.02
17 profile-2 SP1 1.00 0.86 1.20 1.55 1.00 1.16 1.02 1.39
18 profile-2 KLF3 1.00 0.95 1.45 1.86 1.00 0.95 1.83 1.72
19 profile-2 KLF1 1.00 1.75 80.72 108.50 1.00 2.22 6.70 13.80
20 profile-2 POU2F1 1.00 0.91 1.28 1.90 1.00 0.57 1.23 1.16
21 profile-2 KLF13 1.00 0.98 1.12 1.83 1.00 2.16 0.58 8.70
22 profile-2 GATA1 1.00 1.83 94.63 112.31 1.00 1.80 7.40 8.40
23 profile-2 NF-E2 1.00 1.53 10.98 17.47 1.00 17.6 85.80 776.40
24 profile-2 ATF2 1.00 1.25 1.69 2.03 1.00 2.70 1.50 2.40
25 profile-2 FGFR3 1.00 1.20 47.87 39.77 1.00 8.22 956. 923.45
26 profile-2 MAPKK6 1.00 1.01 1.65 2.07 1.00 1.39 1.13 2.12
27 profile-2 HSP90kDa 1.00 0.95 1.65 1.75 1.00 0.63 1.50 8.57
28 profile-2 v-Myc 1.00 1.03 1.70 2.49 1.00 30.5 0.45 2.44
29 profile-2 CUTL1 1.00 1.02 1.58 2.20 1.00 1.02 0.42 2.06
30 Reference 1 ACTB 1.00 1.05 0.84 0.91 1.00 1.00 1.00 1.00
31 Reference 2 18 S 1.00 0.96 1.00 1.06 1.00 0.68 1.62 1.41
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production.
For the second GO category molecular function, pro-
file-1 genes were over-represented in the hydrolase cate-
gory including protein tyrosine phosphatase, MAP
kinase phosphatase, GTP cyclohydrolase and tyrosine/
serine/threonine phosphatase. By contrast, molecular
function GO terms for profile-2 genes included iron,
heme and oxygen binding proteins; profile-3 genes were
related to adenyl nucleotide, ATP and nucleoside bind-
ing proteins. In summary, DAVID GO data mining clas-
sified profile-1 genes as associated with hematopoiesis
w h i l ep r o f i l e - 2g e n e sw e r er e l ated to cell proliferation
and erythrocyte differentiation. Finally, profile-3 genes
were associated with alteration of a macromolecular
complex, or protein switching processes requiring DNA
synthesis.
Functional genomics - Ingenuity Pathway Analysis (IPA)
IPA is software that helps researchers model, analyze,
and understand complex systems by integrating data
from a variety of experimental platforms and providing
insight into molecular and chemical interactions, cellular
phenotypes, and disease processes. We performed IPA
to identify pathways involved in erythropoiesis defined
at p < 0.05 and IPA significance value > 1.3.
The IPA for profile-1 genes with > 1.5-fold decreased
expression over 28 days is shown in Table 3. The most
highly correlated pathways included Cdc42 (cell division
cycle 42, GTP binding protein) (36 hits, p = 14.2), NF-
Kb (33 hits, p = 7.92), Phospholipase C (42 hit, p =
7.13), Interleukin 4 (17 hits, p = 4.78), LXR/RXR (15
hits, p = 3.63) and erythropoietin (14 hits, p = 3.17).
Interestingly, the Cdc42 gene is not differentially
expressed by microarray and RT-qPCR data (Additional
file 2: Table S1, Additional file 3: Table S2, Additional
file 4: Table S3, Additional file 5: Table S4 and Table 2
respectively). Although mRNA levels may not be altered,
Cdc42 signaling can be activated by phosphorylation at
serine 71 [43] with subsequent activation of downstream
effector molecules. The latter proteins such as PAK2 or
SPEC1 may be regulated at the transcriptional and post-
translational levels (Figure 5A) to explain the high score
obtained for the Cdc42 pathway.
Although most of these pathways have not been
directly associated with mechanisms of globin gene reg-
ulation, there are multiple studies to support the invol-
vement of p38 MAPK signaling in erythropoiesis (Figure
5B). For instance by IPA, p38 MAPK is activated by
phospholipase C [44], Cdc42 [45], and LXR/RXR [46]
signaling. Although initially identified as a protein kinase
activated by stress, p38 MAPK signaling coordinates cel-
lular responses during erythropoiesis [47]. For example,
p38 MAPK is essential for the synthesis of hemoglobin
[48] and p38a
-/-mice exhibit severe anemia and die in
utero owing to defects in angiogenesis, and placental
insufficiency [49]. Furthermore, the proliferation and
differentiation of erythroid progenitors is controlled by
erythropoietin through the p38 MAPK pathway [50] and
p38 is required for erythropoietin mRNA stability [51].
Previous data from our laboratory demonstrated that
p38 MAPK signaling plays an important role in drug-
mediated fetal hemoglobin induction in primary ery-
throid cells [52]. Moreover, ATF2, CREBBP and cJun are
required to induce g-globin expression via p38 activa-
tion. The global pathway analysis from profile-1 genes
suggests that p38 MAPK plays a direct role in g-globin
gene regulation independent of drug induction. These
data are in agreement with our recent publication
demonstrating that p38 is required for steady-state g-
globin activation during normal erythropoiesis [53]. The
specific role of other signaling pathways in globin gene
regulation remains to be defined.
In contrast to efforts aimed at understanding mechan-
isms of g-globin gene expression, fewer studies have
focused on b-globin regulation via cell signaling path-
ways. In our pathway analysis of profile-2 genes, we
identified the Mitotic Roles of Polo-Like Kinase (PLK)
pathway (19 hits, p = 7.22) highly associated with b-glo-
bin activation (Table 4 and Additional file 1: Figure
S5C). Although there is no direct evidence for PLK
involvement in globin gene regulation, it is known that
PLK can inhibit histone deacetylase 3 activity [54].
Furthermore, histone deacetylase 3 can inhibit the
TATA box and produce positive regulation of b-globin
expression by enhanced USF and TFII binding [55]. On
the contrary, Perrine and colleagues demonstrated g-
Table 3 Main pathways identified by profile-1 genes
Ingenuity Canonical
Pathways
gene hits -log (p-value)
Cdc42 36 14.2
Phospholipase C 42 7.13
NF-b 33 7.92
Interleukin-4 17 4.78
LXR/RXR Activation 15 3.63
Erythropoietin 14 3.17
PPARa/RXRa ± Activation 21 2.19
Rac 16 2.17
SAPK/JNK 14 1.92
p70S6K 17 1.88
Acute Phase Response 21 1.66
Notch 7 1.64
PPAR 12 1.56
ERK/MAPK 21 1.44
p38 MAPK 13 1.44
Insulin Receptor 16 1.43
Li et al. BMC Genomics 2012, 13:153
http://www.biomedcentral.com/1471-2164/13/153
Page 8 of 18globin gene silencing mediated by a HDAC3-NCoR
repressor complex [56]. These finding suggest some pro-
tein may play a dual role in globin gene regulation.
Numerous other signaling pathways including the Aryl
hydrocarbon receptor, ATM, cell cycle regulation, P53
protein and RAC are activated during adult stage b-glo-
b i ng e n ee x p r e s s i o n[ 5 7 , 5 8 ] . Our studies for profile-2
genes (Table 4) revealed the cell cycle control proteins,
and Aryl hydrocarbon receptor, and ATM pathways
with the highest number of gene hits. Of interest is the
ATM pathway (Additional file 1: Figure S5D) which
phosphorylates several proteins to activate the DNA
damage checkpoint, leading to cell cycle arrest, apopto-
sis and cell differentiation [59]. This pathway also
Figure 5 Pathways identified by IPA.P r o f i l e - 1g e n e sw e r eu s e df o rI P A .T h eA )C d c 4 2a n d B) p38 MAPK signaling pathways identified for
profile-1 genes are shown. The shaded symbols represent gene hits in the pathway and clear symbols representing other known genes in the
signaling pathway (squares = cytokines, oval shape = transcription factors and triangle shape = kinases).
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marrow failure [60]. Recent studies support a role for
ATM in the regulation of erythropoiesis and b-globin
expression however the exact mechanism remains
unclear [61]. ATM was also identified with profile-3
genes (Table 5) suggesting this signaling pathway may
play a more general role in erythroid maturation.
Published data to define the erythroid transcriptome
in human primary progenitors [13-17] have mainly been
established using a variety of liquid culture systems and
a range of 0-43% differentially expressed genes have
been reported. Given the differences in experimental
design for the various studies it is difficult to directly
compare results. The most recent study by Merry-
weather-Clarke et al. [17] is most similar with our
design except they used the two-phase liquid culture
design established by Fibach et al. [62] and a FACS sort-
ing step to isolate purified erythroid progenitors for
gene profiling. They reported the highest level of differ-
entially expressed genes at 47% and identified potential
new targets involved in erythroid maturation. By com-
parison, we identified 38% differentially expressed genes
and identified similar cellular pathways involved in ery-
throid maturation by IPA and DAVID GO analysis. Our
study is unique in that none of the published studies
performed in silico transcription factor binding analysis
based on major gene profiles to gain insights into the g/
b globin switching described below.
Functional genomics - identification of b-locus
transcription factor binding sites
In the final set of analyses our goal was to identify tran-
scription factor binding sites for profile-1, -2, and -3
proteins identified by PCA. The regions shown in Figure
6A and 6B were chosen based on the speculation that
profile-1 genes (silenced from day 7 to day 28) might be
trans-activators of g-globin expression since they are
expressed in a similar pattern as other factors demon-
strated to activate g-globin. Likewise, profile-2 genes
(activated from day 7 to day 28) might be involved in b-
globin regulation. The alternative possibility that profile-
1 and profile-2 genes are b-o rg-globin silencers respec-
tively was not tested. With this goal in mind, we per-
formed in silico analysis using TESS, TFSEARCH,
Weeder H, and FIRE platforms and DNA sequences
from the Human Genome (Hg19 version; NG_00007.3)
to identify predicted binding sites in the b-locus. Shown
in Figure 6 are schematics of the regions targeted for
these analyses. We examined the locus control region
(LCR) consisting of five developmentally stable DNaseI
hypersensitive sites (HSs) of which HS1 to HS4 are ery-
throid-specific [63]. This regulatory element is known to
bind multiple erythroid and ubiquitous transcription fac-
tors and to mediate a critical enhancer function required
for developmentally regulated globin gene expression. A
unique property of the LCR is its ability to confer inte-
gration position-independent expression on a linked
gene, however only HS2 act as a classical enhancer ele-
ment [3]. In addition to the LCR, we tested gene-specific
regions including approximately 5000 bp upstream of
the HBG2 capsite, to 5000 bp downstream of the HBG1
gene (Figure 6A). These regions were investigated for
binding sites of protein-1 genes silenced > 1.5-fold from
day 7 to day 28.
We identified 22 transcription factors with potential
binding sites in the LCR and g-globin gene regions. For
example, the GATA factors (GATA1, 2 and 3) which are
essential for normal hematopoiesis. GATA2 expression
overlaps with GATA1 during erythroid, megakaryocytic,
eosinophilic and mast cells development [64]. Consistent
with our prediction model for profile-1 genes (Addi-
tional file 8: Table S7), GATA2 over expression in K562
cells mediates activation of the erythroid-specific genes
a-a n dg-globin [65]. In committed erythroid progeni-
tors, GATA2 is replaced by GATA1. Both GATA factors
co-exist in various protein complexes such as SCL/
LMO2/E2A/Ldb-1 and NFE2 which have been demon-
strated to bind directly to globin gene promoters [66].
Table 4 Main pathways identified by profile-2 genes
Ingenuity Canonical Pathways gene
hits
-log(p-
value)
Mitotic Roles of Polo-Like Kinase 19 7.22
CHK Proteins in Cell Cycle Checkpoint Control 14 5.96
Cell Cycle: G2/M DNA Damage Checkpoint
Regulation
13 5.02
Aryl Hydrocarbon Receptor 24 3.74
ATM 13 3.66
Cell Cycle: G1/S Checkpoint Regulation 11 2.34
p53 15 2.04
RAC 16 1.90
Cell Cycle Regulation by BTG Family Proteins 7 1.62
Table 5 Main pathways identified by profile-3 genes
Ingenuity Canonical Pathways gene
hits
-log(p-
value)
Role of CHK Proteins in Cell Cycle Checkpoint
Control
10 4.98
ATM 10 3.17
Cell Cycle: G1/S Checkpoint Regulation 9 2.40
Cell Cycle: G2/M DNA Damage Checkpoint
Regulation
7 2.15
Aryl Hydrocarbon Receptor Signaling 15 2.02
RAN 4 1.91
LPS/IL-1 Mediated Inhibition of RXR Function 19 1.86
Nucleotide Excision Repair Pathway 6 1.81
Fructose and Mannose Metabolism 9 1.34
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Figure 6 Identification of transcription factor binding sites in the b-locus. A) Shown is a schematic diagram of the DNA sequence positions
(NG_000007.3) used in the TESS, TFSEARCH, Weeder H and Fire analysis for profile-1 genes. The figure is not drawn to scale. Abbreviations: LCR,
locus control region; NCR(g), noncoding region HBG2; NCR(b), noncoding region HBB. See methods for more details of DNA sequence location.
B) Shown is a schematic diagram of the genomic locations used in the transcription factor binding site analysis for profile-2 genes. Binding sites
for profile-3 genes were identified using a combination of panels A and B sequences (LCR, NCR(g), HBG2/HBG1, NCR(b), and HBB regions). C)
Hierarchical clustering analysis was performed for profile-1, -2 and -3 genes predicted to have binding sites in the b-locus. The data were
analyzed as described in Figure 4B. The transcription factors are labeled on the right side of the image.
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and a direct role in globin regulation has not been
documented. Other factors such as C/EBPA,w h i c h
binds as a homodimer to certain promoters, can also
forms heterodimers with the related proteins C/EBPB
[67]. These proteins have been implicated as positive
regulators of g-globin through the distal CCAAT box.
In the DNA-binding site studies we also identified the
signal transducers and activators of transcription (Stat)
proteins. Stat1 and Stat2 form heterodimers in response
to erythropoietin stimulation, however, others have
reported that Stat1a and Stat3 can act as negative regu-
lators in erythropoietin-induced erythroid differentiation
[68]. Our laboratory demonstrated a negative role for
Stat3b in g-globin expression while Stat3a played a
positive role [69]. Subsequent studies from our group
demonstrated that Stat3 competes with GATA1 binding
to an element located between +9 to +16 in the g-globin
gene 5’ untranslated region [70].
The subsequent in silico analysis for profile-2 genes
was conducted with sequences in the LCR and about
5700 bp upstream of HBB to the end of the b-locus
(Figure 6B and Additional file 9: Table S8). Several fac-
tors known to be involved in hematopoiesis were identi-
fied such as the lineage-restricted transcription factors
GATA1, SCL/Tal1, LMO2, LDB1 and KLF1 [71]. As
expected, we identified KLF1 the most extensively char-
acterized regulator of HBB expression and erythrocyte
development [32]. It is a zinc finger protein that recog-
nizes a subset of CACC motifs and acts primarily as a
transcriptional activator [72]. Recent data demonstrated
ar o l ef o rKLF1 in BCL11A activation to produce g-glo-
bin silencing [73]. Interestingly, our microarray data
show a 20.6-fold increase in BCL11A expression from
day 7 to day 28 (Additional file 6: Table S5) which is
consistent with its demonstrated role as a g-globin silen-
cer [74-76]. In the b-locus, BCL11A is bound in HS3,
approximately 3 kb downstream of HBG1 and upstream
of HBD [74]. The specificity of the BCL11A binding site
5’ CCAC(c/g) is variable [6]. In our in silico analysis,
BCL11A was not predicted to bind the LCR or down-
stream HBG1 regions. This may be due to variations in
the consensus binding sites and/or differences in the
software algorithms used in the four platforms to iden-
tify binding sites. Our design did not include the HBD
region and only transcription factors with predicted
binding sites in all programs were retained on the list.
Alternatively, BCL11A may not directly bind in the b-
locus rather produce its effect by protein-protein inter-
actions. This mechanism is supported by the ability of
BCL11A to interact with GATA-1, HDAC1 and
HDAC2 [74] and Sox 6 [77] among other proteins. On
the other hand, we identified the known NFE2 binding
sites in HS2; NFE2 recognizes the TCAT/C sequence of
the AP-1-like core palindrome sequence present in a
number of erythroid genes. NFE2 also has been shown
to play an important role in b-globin gene regulation
[78].
Finally, for profile-3 genes we analyzed all regions
described for profile-1 and -2 genes reasoning that fac-
tors associate with the g/b switch might bind through-
out the b-locus. We identified six transcription factors
(Additional file 10: Table S9) with predicted binding
sites upstream of HS1 (NME1), in HS3 (NME2), both g-
globin genes (POU4F1), 5’ of b-globin (MYB and
GATA5) and in 5’ HS3 (WT1). One of the most impor-
tant regulators of mammalian hematopoiesis is c-MYB,
an evolutionarily conserved transcription factor [79]
highly expressed in immature hematopoietic cells and
down-regulated during differentiation. We observed
peak expression around day 21 consistent with pub-
lished data. Bianchi and colleagues [80] demonstrated
that c-MYB silencing in CD34
+ stem cells increased
commitment toward the macrophage and megakaryo-
cyte lineages, whereas erythroid differentiation was
impaired. Furthermore, gene expression profiling analy-
sis identified KLF1 and LIM Domain Only 2 as putative
targets, which could account for the effects of c-MYB
knockdown. A genome-wide association study has
shown polymorphisms in the HBS1L-MYB intergenic
(HMIP) region are highly associated with elevated fetal
hemoglobin levels in Chinese b-thalassemia heterozy-
gotes [81]. The exact mechanism by which these var-
iants result in elevated fetal hemoglobin remains
unclear, although it has been suggested MYB may med-
iate this effect [82].
The Wilms’ tumor protein Wt1 is another interesting
profile-3 gene with predicted binding in the b-locus. It
is required for embryonic development and has been
implicated in hematologic disorders [83]. Wt1 deficiency
may also compromise the proliferation and differentia-
tion of erythroid progenitor cells [84]. A cis-element in
the erythropoietin receptor promoter of human and
mouse genes was identified by mutation analysis. The
authors conclude that activation of the erythropoietin
receptor gene by Wt1 may represent an important
mechanism in normal erythropoiesis.
Our findings suggest that transcription factors identi-
fied with potential binding sites in the b-locus by in
silico analysis (Figure 6C) may have biological relevance
to HBG and HBB gene regulation. We tested our
hypothesis by analyzing two factors KLF4 (Figure 3B)
and KLF12; in a recently published study [85]. By elec-
trophoresis mobility shift assay, we demonstrated that
KLF4 and KLF12 directly bind the g-globin CACCC ele-
m e n t .H o w e v e r ,o n l yKLF4 mediated positive regulation
of g-globin expression in cell lines and primary erythroid
progenitors. Interestingly, the in silico studies only
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tional file 8: Table S7).
Additional support for our experimental approach can
be gained from C/EBP proteins which have been
demonstrated to activate g-globin through binding of
the distal CCAAT box [67]; C/EBP compete for binding
of the repressor protein CCAAT displacement protein
[86]. In fact, this is the proposed mechanism for heredi-
tary persistence of fetal hemoglobin due to a C/T muta-
tion at -117 in the distal CCAAT box [87]. These
findings provide evidence that other transcription fac-
tors involved in globin gene regulation can be identified
in our system.
Conclusions
The one-phase liquid culture system was used to define
the erythroid transcriptome associated with the g/b-glo-
bin gene switch in vitro and to address global mechan-
isms involved in globin gene regulation. We utilized
primary erythroid cells to characterize three major gene
expression patterns including profile-1 genes silenced
from day 7 to day 28, profile-2 genes activation from
day 7 to day 28 and profile-3 genes with peak expres-
sion at day 21 around the time of the g/b-globin switch.
After erythroid differentiation the transcriptome was
established using the Illumina BeadChip microarray
platform. Profile-1 genes were related to hemopoeisis
and the NF-Kb, Interleukin-4 and p38 MAPK signaling
pathways. Profile-2 genes were shown to be associated
with cell proliferation, heme synthesis and erythrocyte
differentiation. Finally profile-3 genes were associated
with nucleotide metabolism, and protein switching. The
biological subgroups generated by our data corroborate
published studies related to erythroid maturation and
hemoglobin synthesis during terminal differentiation.
New insights into the switching process will be obtained
by further investigation of biological subgroups associate
with the g/b switch observed at day 21 in culture.
Methods
Primary erythroid culture system
Peripheral blood mononuclear cells were isolated from
three normal donors (Carter Blood Center, Bedford,
TX) using Histapaque-1.077 (Cellgro Inc.). The mono-
nuclear cells were grown in three independent cultures
using the one-phase protocol as previously published
[18]. Briefly, cells were cultured in aMEM containing
30% fetal bovine serum (Atlanta Biologicals, Atlanta
GA), 1% deionized BSA with penicillin (100 U/mL) and
streptomycin (0.1 mg/mL) at 37°C and 5% CO2. The fol-
lowing growth factors were added on day 0: stem cell
factor (50 ng/mL), Interleukin-3 (10 ng/mL) and ery-
thropoietin (4 U/mL). See details of our one-phase cul-
ture protocol in Additional file 11: Supplemental
Methods. Approximately 1.5 million cells were harvested
every 2-3 days from each culture for RNA isolation and
morphological studies by cytospin preparations fixed in
100% methanol and stained with Giemsa. Cell counts
and morphology were performed on a light microscope
under oil emersion; at least 500 cells were counted on
each slide.
RT-qPCR analysis
The mRNA levels of g-globin, b-globin, and glyceralde-
hyde-3-phosphate dehydrogenase (GAPDH) were mea-
sured as previously published [52,53,85] to establish the
g/b globin switch in culture. Total RNA was extracted
from 5 × 10
6 cells at each time point from the three
independent cultures using a Trizol kit (Invitrogen,
Carlsbad, CA) according to the manufacturer’si n s t r u c -
tions. RNA qualities were confirmed by Bio-Rad
Experion automated electrophoresis. Based on published
criteria all samples used in our analysis had RQI values
> 8.0. cDNA was prepared from total RNA (1 μg) using
the Improm-II reverse transcriptase (RT) system (Pro-
mega, Madison, WI). The g-globin, b-globin, and
GAPDH mRNA levels were quantified by qPCR (iCycler
iQ; Bio-Rad, Hercules, CA) and standard curves were
generated using a Topo7-based plasmid carrying the g-
globin (Topo7- b-globin), Topo7- b-globin, or Topo7-
GAPD cDNA.
Illumina BeadChip microarray analysis
Total RNA isolated on day 7, 14, 21 and 28 was used for
microarray analysis on the whole-genome Illumina
HumanWG-6V2 Expression BeadChip with 48,700
probes (Illumina, Inc., San Diego, CA) per the manufac-
turer’s protocol. Briefly, RNA samples (0.5 μg) were
amplified using Illumina TotalPrep RNA amplification
kit (Enzo, Austin, TX) with biotin UTP labeling. Single
stranded cDNA was generated using a T7 oligo(dT) pri-
m e rf o l l o w e db ys e c o n ds t r and synthesis to generate
double-stranded cDNA which was column purified. Bio-
tin-labeled cRNA was synthesized by in vitro transcrip-
tion using T7 RNA polymerase which was column
purified, and checked for quality using the Bio-Rad
Experion system (Hercules, CA). cRNA (1.5 μg) was
hybridized to the Illumina BeadChip per protocol and
streptavidin-Cy3 (Amersham, Piscataway, NJ) was used
for detection. Chips were scanned on an Illumina
Beadstation.
The following RT-qPCR approach confirmed the
microarray data. Total RNA was isolated using the Tri-
zol kit (Invitrogen) according to the manufacturer’s
instructions. RNA solutions were treated with DNase I
before RT then cDNA was synthesized in a reaction
containing SuperScript III RT (Invitrogen) and random
hexamer primers. Gene specific primers were designed
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PCR reactions were performed using a SYBR PCR mas-
ter mix kit (AB Biosystems, Inc. Carlsbad, CA), and a
Chromo4 Fluorescence Detector (Bio-Rad). The PCR
protocol included denaturation at 95°C for 10 min, fol-
lowed by 40 cycles of 95°C for 15 s and 60°C for 1 min
and 18S or GAPDH RNA were used as internal con-
trols. Serial dilutions of cDNAs generated from refer-
ence RNA (Strategene Inc., La Jolla, CA) were used to
establish standard curves for each gene. The qPCR
results were analyzed using Opticon software (Bio-Rad).
Bioinformatics and biostatistics analysis
The raw data obtained from the scanner were summar-
ized as probe level signal intensities using Illumina
BeadStudio v2.1.3 (Illumina), then background subtrac-
tion and quantile normalization (Additional file 1: Figure
S4A) were completed using the MBCB algorithm [88].
After data normalization, we performed time-course
analysis with PCA software (NIA Array Analysis Tool
http://lgsun.grc.nia.nih.gov/ANOVA/bin/login.cgi) to
characterize three major genomic profiles [89]. For
P C A ,t h eg e n o m i c sd a t aw e r em i n e dt of o l l o wt h e
expression patterns of g-a n db- globin during erythro-
poiesis which is best analyzed based on the F-distribu-
tion with ANOVA = 0.01 and FDR = 0.05. Because we
wanted to maintain globin gene profiles during our eva-
luation, permutation analysis was not conducted. The
different profiles were analyzed at the > 1.25-fold, > 1.5-
fold, and > 2.0-fold change levels in a time-course man-
ner on day 7, 14, 21 and 28 to define three major gene
profiles. For subsequent bioinformatics analyses, we
used genes with > 1.5-fold change in expression (Addi-
tional file 6: Table S5).
To support the results of PCA, Hierarchical Clustering
methods were also used. Profile-1, profile-2 and profile-
3 with 1.25-fold, 1.5-fold, and 2.0-fold change were
input into BRB ArrayTools http://linus.nci.nih.gov/BRB-
ArrayTools.html[90]. After log-transformation the inten-
sity values were loaded into the Gene Cluster 3.0, BRB
platform. The various genes (rows) and culture times
(columns) were clustered using the correlation distances
with similarity metric and average linkage. Finally, a
heat-map was generated using the average gene expres-
sion fold-change values at the different time points to
demonstrate up-regulated genes (red), gene silencing
(green) and day 7 normalized to one or no change in
gene expression (black). Three major genomic profiles
including profile-1 (gene silencing from day 7-28), pro-
file-2 (gene activation from day 7-28) and profile-3 with
peak expression at day 21 were generated. These data
are available through the National Center for Biotech-
nology Information Gene Expression Omnibus [91]
using accession number ID GSE35102.
T ov a l i d a t et h em i c r o a r r a yd a t aw ec h o s eas u b s e to f
genes to analyze by RT-qPCR and performed statistical
analysis to determine the correlation between microar-
ray and RT-qPCR data. Subsets of profile-1 and profile-
2 genes were analyzed using the correlation coefficient,
R
2 and confidence intervals of parameter were also gen-
erated in the statistical analysis. Descriptive statistics for
microarray and RT-qPCR data including raw counts,
means and standard error were used to present the dis-
tribution of the measured parameters. Statistical assess-
ment of these characteristics at different time points for
microarray was performed using the Student’s t-test (p
< 0.05 was considered significant).
DAVID GO analysis
DAVID GO software http://david.niaid.nih.gov was used
to classify the large number of genes mined into biologi-
cal functional groups. The gene subgroups were loaded
into the GO platform and then a) the data were ana-
lyzed and Kappa scores calculated to evaluate the
mining process; b) the transcriptome of each profile was
categorized by biological process and molecular function
using an over-representation analysis.
Functional genomics analysis
The pathway analyses from the mined genes were per-
formed using IPA (IPA Ingenuity Systems, Inc., Red-
wood City, CA) software. Core analysis was processed
using direct and indirect relationships for pathway scor-
ing. Profile-1, profile-2, and profile-3 genes were investi-
gated using the IPA software according to the
manufacturer’s instruction. The final data were reported
by Pathway map and “txt” version with a hit list; P-
values < 1.3 log (-) was used as a cut off for statistical
significance [91].
Transcription factor analysis
To search for putative transcription factor binding sites
in the b-globin locus on chromosome 11 the following
software programs were used: TESS (http://www.cbil.
upenn.edu/cgi-bin/tess/tess[92], TFSEARCH http://mbs.
cbrc.jp/research/db/TFSEARCH.html) [93], FIRE http://
quantbio-tools.princeton.edu/cgi-bin/FIRE/form.pl[94]
and Weeder H version 1.0 [95]. The Genome Browser
http://genome.ucsc.edu/ was employed to confirm motif
coordinates in the Human Genome (version Hg 19).
DNA sequences from the LCR, the 5’ upstream HBG1
region, coding sequence for HBG1 and HBG2,a n d3 ’
downstream sequence (Figure 6A) were analyzed with
the four platforms to identify putative binding sites for
profile-1 genes. A second analysis of the LCR, HBB 5’
upstream, coding and 3’ downstream regions was com-
pleted to identify putative binding sites for profile-2
genes. Potential transcription factor binding sites for
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regions tested for profile-1 and -2 genes.
Additional material
Additional file 1: Figure S1. RNA quality check. Figure S4A Multiple
regression analysis. Figure S5C Mitotic Roles of Polo-Like Kinasae
signaling pathway. Figure S5D ATM signaling pathway.
Additional file 2: Table S1. Day 7 Illumina HumanWG-6V2 Expression
BeadChip raw data. This file contains a table listing microarray raw data
including the mean (M) and standard error (SEM) for each gene
calculated from triplicate RNA samples extracted on day 7 from cells
grown in the one-phase liquid culture system. Briefly, total RNA with
amplified and biotin-labeled and then used for hybridization to the
Illumina HumanWG-6V2 Expression BeadChip. Microarray raw data were
generated on the Illumina Beadstation scanner.
Additional file 3: Table S2. Day 14 Illumina HumanWG-6V2 Expression
BeadChip raw data. This file contains a table listing microarray raw data
including the mean (M) and standard error (SE) for each gene calculated
from triplicate RNA samples extracted on day 14 from cells cultured in
the one-phase liquid culture system. Briefly, total RNA with amplified and
biotin-labeled and then used for hybridization to the Illumina
HumanWG-6V2 Expression BeadChip. Microarray raw data were
generated on the Illumina Beadstation scanner.
Additional file 4: Table S3. Day 21 Illumina HumanWG-6V2 Expression
BeadChip raw data. This file contains a table listing microarray raw data
including the mean (M) and standard error (SE) for each gene calculated
from triplicate RNA samples extracted on day 21 from cells cultured in
the one-phase liquid culture system. Briefly, total RNA with amplified and
biotin-labeled and then used for hybridization to the Illumina
HumanWG-6V2 Expression BeadChip. Microarray raw data were
generated on the Illumina Beadstation scanner.
Additional file 5: Table S4. Day 28 Illumina HumanWG-6V2 Expression
BeadChip raw data. This file contains a table listing microarray raw data
including the mean (M) and standard error (SE) for each gene calculated
from triplicate RNA samples extracted on day 28 from cells cultured in
the one-phase liquid culture system. Briefly, total RNA with amplified and
biotin-labeled and then used for hybridization to the Illumina
HumanWG-6V2 Expression BeadChip. Microarray raw data were
generated on the Illumina Beadstation scanner.
Additional file 6: Table S5. Differential gene expression generated by
PCA. This file contains three tables listing genes with > 1.5-fold change
in expression during erythroid maturation in our one-phase liquid culture
system. PCA data show the log change; a positive value indicates
decreased gene expression from day 7 to day 28 in contrast to increased
gene expression indicated by a negative log change. The correlation
score indicates the level of agreement between the specific globin gene
profile curve and PCA values.
Additional file 7: Table S6. Gene Ontology analysis from profile-1, -2
and -3 gene subsets. This file contains a complete list of the DAVID GO
terms generated for the three gene groups tested; the count number
indicates how many genes were identified in the specific pathway by
microarray analysis. The p values indicate the significance level for the
specific pathways identified. The Benjamin score represents the adjusted
multiple p values to take into account all genes involved in the
pathways identified.
Additional file 8: Table S7. TESS, TFSEARCH, Weeder H and Fire analysis
for profile-1 genes.
Additional file 9: Table S8. TESS, TFSEARCH, Weeder H and Fire analysis
for profile-2 genes.
Additional file 10: Table S9. TESS, TFSEARCH, Weeder H and Fire
analysis for profile-3 genes.
Additional file 11: Supplemental Methods. Method for the one-phase
tissue culture system.
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